Navigation Links
Massague honored with inaugural AACR Distinguished Leadership Award in Breast Cancer Research

SAN ANTONIO Joan Massagu, Ph.D., whose research identified the role of transforming growth hormone factor-Beta (TGF-Beta) in the metastasis of breast cancer cells to the lung, has been selected to receive the inaugural AACR Distinguished Leadership Award in Breast Cancer Research.

Massagu spent more than two decades defining how TGF-Beta affects cell growth and division. He learned that an imbalance of TGF-Beta receptors led to the spread of cancer cells and used this information to determine how gene expression predicts the ability of breast cancer cells to metastasize. Massagu identified organ-specific metastatic characteristics that predict the spread of cancer cells. These investigations demonstrated that a genetic predisposition for metastasis can sometimes be identified in primary malignancies before the cancer has begun to spread.

Massagu's work is a dramatic example of the continuing importance of the focused pursuit of basic problems in biology for advancing our understanding of cancer and for developing new approaches to diagnosis and treatment.

Massagu obtained his doctorate in biochemistry from the University of Barcelona. In 1989, he was recruited to Memorial Sloan-Kettering Cancer Center. He currently serves as Investigator, Howard Hughes Medical Institute; professor, Weill-Cornell Graduate School; adjunct director, Institute for Research in Biomedicine of Barcelona; and Alfred P. Sloan Chair, Cancer Biology and Genetics Program at Memorial Sloan-Kettering Cancer Center.

Massagu will give an award lecture entitled, "Deconstructing Metastasis," on Saturday, December 13, 2008, at 11:30 a.m. CST, during the 31st Annual CTRC-AACR San Antonio Breast Cancer Symposium, in San Antonio, Texas.


Contact: Megan Davies
American Association for Cancer Research

Page: 1

Related biology news :

1. UTMB researchers to be honored at Oscars of invention
2. ESA honored at White House ceremony
3. UT Southwestern scientist honored among best in Texas research
4. Rices West honored as one of Texas best researchers
5. Jeremy Jackson honored by Harvard Museum of Natural History
6. NJIT Provost Priscilla P. Nelson honored at National Academy of Engineering
7. Yales Anastas honored for leadership in founding of green chemistry
8. Springer editor honored with top environmental prize
9. Sen. Byron Dorgan to be honored
10. Leader of Human Genome Project honored with the Inamori Ethics Prize
11. Inaugural Kavli laureates honored in Oslo ceremony
Post Your Comments:
(Date:6/20/2016)... 2016 Securus Technologies, a leading provider ... public safety, investigation, corrections and monitoring announced that ... has secured the final acceptance by all three ... Access Systems (MAS) installed. Furthermore, Securus will have ... installed by October, 2016. MAS distinguishes between legitimate ...
(Date:6/7/2016)... TORONTO , June 7, 2016  Syngrafii ... begun a business relationship that includes integrating Syngrafii,s ... pilot branch project. This collaboration will result in ... for the credit union, while maintaining existing document ... ...
(Date:6/1/2016)... YORK , June 1, 2016 ... Technology in Election Administration and Criminal Identification to Boost ... to a recently released TechSci Research report, " Global ... By Region, Competition Forecast and Opportunities, 2011 - 2021", ... 24.8 billion by 2021, on account of growing security ...
Breaking Biology News(10 mins):
(Date:6/27/2016)... GUELPH, ON , June 27, 2016 /PRNewswire/ - BIOREM ... it has been advised by its major shareholders, Clean ... LP, United States based venture ... common shares of Biorem (on a fully diluted, as ... for the disposition of their entire equity holdings in ...
(Date:6/27/2016)... , ... June 27, 2016 , ... Parallel 6 ... trials, announced today the Clinical Reach Virtual Patient Encounter CONSULT module which ... with the physician and clinical trial team. , Using the CONSULT module, patients and ...
(Date:6/27/2016)... PHILADELPHIA , June 27, 2016  Liquid ... today announced the funding of a Sponsored Research ... study circulating tumor cells (CTCs) from cancer patients.  ... changes in CTC levels correlate with clinical outcomes ... therapies. These data will then be employed to ...
(Date:6/24/2016)... Epic Sciences unveiled a liquid biopsy ... PARP inhibitors by targeting homologous recombination deficiency (HRD) ... test has already been incorporated into numerous clinical ... Over 230 clinical trials are investigating ... PARP, ATM, ATR, DNA-PK and WEE-1. Drugs targeting ...
Breaking Biology Technology: